Eversept Partners, LP Medpace Holdings, Inc. Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$233.98 - $281.67 $1.58 Million - $1.9 Million	-6,741 Reduced 43.31%	8,823 $2.14 Million
Q2 2023 Nov 08, 2023	BUY	$187.26 - $240.17 $729,564 - $935,702	3,896 Added 33.39%	15,564 $3.74 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $729,564 - $935,702	3,896 Added 33.39%	15,564 $3.74 Million
Q1 2023 Nov 08, 2023	SELL	$174.31 - $239.52 $679,111 - $933,169	-3,896 Reduced 25.03%	11,668 $2.19 Million
Q1 2023 May 15, 2023	BUY	$174.31 - $239.52 $2.03 Million - $2.79 Million	11,668 New	11,668 $2.19 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.